Ali Zamani1, Corinne Decker1, Viviana Cremasco1, Lindsey Hughes1, Deborah V Novack2,3, Roberta Faccio1. 1. Department of Orthopaedics, Washington University School of Medicine, St. Louis, MO, USA. 2. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. 3. Division of Bone and Mineral, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Abstract
Increased diacylglycerol (DAG) levels are observed in numerous pathologies, including conditions associated with bone loss. However, the effects of DAG accumulation on the skeleton have never been directly examined. Because DAG is strictly controlled by tissue-specific diacylglycerol kinases (DGKs), we sought to examine the biological consequences of DAG accumulation on bone homeostasis by genetic deletion of DGKζ, a highly expressed DGK isoform in osteoclasts (OCs). Strikingly, DGKζ(-/-) mice are osteoporotic because of a marked increase in OC numbers. In vitro, DGKζ(-/-) bone marrow macrophages (BMMs) form more numerous, larger, and highly resorptive OCs. Surprisingly, although increased DAG levels do not alter receptor activator of NF-κB (RANK)/RANK ligand (RANKL) osteoclastogenic pathway, DGKζ deficiency increases responsiveness to the proliferative and pro-survival cytokine macrophage colony-stimulating factor (M-CSF). We find that M-CSF is responsible for increased DGKζ(-/-) OC differentiation by promoting higher expression of the transcription factor c-Fos, and c-Fos knockdown in DGKζ(-/-) cultures dose-dependently reduces OC differentiation. Using a c-Fos luciferase reporter assay lacking the TRE responsive element, we also demonstrate that M-CSF induces optimal c-Fos expression through DAG production. Finally, to demonstrate the importance of the M-CSF/DGKζ/DAG axis on regulation of c-Fos during osteoclastogenesis, we turned to PLCγ2(+/-) BMMs, which have reduced DAG levels and form fewer OCs because of impaired expression of the master regulator of osteoclastogenesis NFATc1 and c-Fos. Strikingly, genetic deletion of DGKζ in PLCγ2(+/-) mice rescues OC formation and normalizes c-Fos levels without altering NFATc1 expression. To our knowledge, this is the first report implicating M-CSF/DGKζ/DAG axis as a critical regulator of bone homeostasis via its actions on OC differentiation and c-Fos expression.
Increased diacylglycerol (span>n class="Gene">DAG) levels are observed in numerous pathologies, including conditions associated with bone loss. However, the effects of DAG accumulation on the skeleton have never been directly examined. Because DAG is strictly controlled by tissue-specific diacylglycerol kinases (DGKs), we sought to examine the biological consequences of DAG accumulation on bone homeostasis by genetic deletion of DGKζ, a highly expressed DGK isoform in osteoclasts (OCs). Strikingly, DGKζ(-/-) mice are osteoporotic because of a marked increase in OC numbers. In vitro, DGKζ(-/-) bone marrow macrophages (BMMs) form more numerous, larger, and highly resorptive OCs. Surprisingly, although increased DAG levels do not alter receptor activator of NF-κB (RANK)/RANK ligand (RANKL) osteoclastogenic pathway, DGKζ deficiency increases responsiveness to the proliferative and pro-survival cytokine macrophage colony-stimulating factor (M-CSF). We find that M-CSF is responsible for increased DGKζ(-/-) OC differentiation by promoting higher expression of the transcription factor c-Fos, and c-Fos knockdown in DGKζ(-/-) cultures dose-dependently reduces OC differentiation. Using a c-Fos luciferase reporter assay lacking the TRE responsive element, we also demonstrate that M-CSF induces optimal c-Fos expression through DAG production. Finally, to demonstrate the importance of the M-CSF/DGKζ/DAG axis on regulation of c-Fos during osteoclastogenesis, we turned to PLCγ2(+/-) BMMs, which have reduced DAG levels and form fewer OCs because of impaired expression of the master regulator of osteoclastogenesis NFATc1 and c-Fos. Strikingly, genetic deletion of DGKζ in PLCγ2(+/-) mice rescues OC formation and normalizes c-Fos levels without altering NFATc1 expression. To our knowledge, this is the first report implicating M-CSF/DGKζ/DAG axis as a critical regulator of bone homeostasis via its actions on OC differentiation and c-Fos expression.
Authors: Mary L Bouxsein; Stephen K Boyd; Blaine A Christiansen; Robert E Guldberg; Karl J Jepsen; Ralph Müller Journal: J Bone Miner Res Date: 2010-07 Impact factor: 6.741
Authors: Yingsu Huang; Haining Zhang; Zongjun Shao; Kimberley A O'Hara; Melanie A Kopilas; Liping Yu; Thomas Netticadan; Hope D Anderson Journal: Cardiovasc Res Date: 2010-12-23 Impact factor: 10.787
Authors: Viviana Cremasco; Corinne E Decker; Deborah Stumpo; Perry J Blackshear; Keiichi I Nakayama; Keiko Nakayama; Traian S Lupu; Daniel B Graham; Deborah V Novack; Roberta Faccio Journal: J Bone Miner Res Date: 2012-12 Impact factor: 6.741
Authors: Mette G Sørensen; Morten A Karsdal; Morten H Dziegiel; Jean A Boutin; Olivier Nosjean; Kim Henriksen Journal: BMC Musculoskelet Disord Date: 2010-10-26 Impact factor: 2.362
Authors: Zoi Drosatos-Tampakaki; Konstantinos Drosatos; Yasemin Siegelin; Shan Gong; Salmiyeh Khan; Thomas Van Dyke; Ira J Goldberg; P Christian Schulze; Ulrike Schulze-Späte Journal: J Bone Miner Res Date: 2014 Impact factor: 6.741
Authors: Wi S Lai; Deborah J Stumpo; Melissa L Wells; Artiom Gruzdev; Stephanie N Hicks; Cindo O Nicholson; Zhengfeng Yang; Roberta Faccio; Michael W Webster; Lori A Passmore; Perry J Blackshear Journal: Mol Cell Biol Date: 2019-06-13 Impact factor: 4.272